Los Angeles Capital Management
CGON icon

Los Angeles Capital Management’s CG Oncology CGON Stock Holding History

Los Angeles Capital Management’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.3K Hold
159
– – ﹤0.01% 1934
2026
Q1 		$10.8K Sell
159
-10
-6% -$567 ﹤0.01% 1935
2025
Q4 		$7.18K Buy
+169
New +$6.99K ﹤0.01% 2198
2025
Q3 		– Sell
-11,197
Closed -$291K – 1381
2025
Q2 		$291K Sell
11,197
-16,325
-59% -$393K ﹤0.01% 1062
2025
Q1 		$674K Sell
27,522
-2,675
-9% -$75.2K ﹤0.01% 680
2024
Q4 		$866K Buy
30,197
+8,145
+37% +$279K ﹤0.01% 664
2024
Q3 		$832K Buy
+22,052
New +$773K ﹤0.01% 705

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Los Angeles Capital Management's CGON Position: Q2 2026 in Review

Los Angeles Capital Management held its CG Oncology (CGON) position steady in Q2 2026 at 159 shares worth $11.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1934.

Los Angeles Capital Management first reported a position in CGON in Q3 2024 and has held it in 7 quarters since. The position peaked at $866K in Q4 2024. 227 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • Los Angeles Capital Management held 159 shares of CG Oncology worth $11.3K as of Q2 2026.
  • Los Angeles Capital Management left its CG Oncology share count unchanged in Q2 2026.
  • CG Oncology made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q2 2026, its #1934 holding.
  • Los Angeles Capital Management first reported a position in CG Oncology in Q3 2024 and has held it in 7 quarters since.
  • Los Angeles Capital Management's CG Oncology position peaked at $866K in Q4 2024.
  • 227 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on Los Angeles Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.